GRACE ARTRIP: Open Payments
NPI 1508508557 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $557
Food & beverage: $478Education: $79
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $272 |
| Exeltis, USA Inc. | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $45 |
| Seqirus USA Inc | 2 | $36 |
| Hologic Sales and Service, LLC | 1 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $30 |
| PFIZER INC. | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $20 |
Products named: Veozah, SLYND, Flucelvax, APTIMA, ACCRUFER, ABRYSVO, BEYFORTUS, GEMTESA.
Industry payments across VA — which companies pay providers there.
